Diseases and disorders |
Name |
P value |
Number of molecules |
Cancer |
2.08E-12 - 1.59E-02 |
277 |
Gastrointestinal disease |
8.03E-12 - 1.60E-02 |
149 |
Reproductive system disease |
2.25E-09 - 1.57E-02 |
138 |
Hematological disease |
1.72E-06 - 1.22E-02 |
70 |
Hereditary disorder |
2.10E-06 - 1.57E-02 |
120 |
|
Molecular and cellular functions |
Name |
P value |
Number of molecules |
Cell cycle |
1.06E-20 - 1.60E-02 |
158 |
Cellular assembly and organization |
1.06E-20 - 1.36E-02 |
111 |
DNA replication, recombination, and repair |
1.06E-20 - 1.16E-02 |
133 |
Cellular movement |
8.36E-11 - 1.51E-02 |
82 |
Cell death |
2.98E-06 - 1.56E-02 |
216 |
Top canonical pathways |
Name |
P value |
Ratio |
Role of BRCA1 in the DNA damage response |
9.79E-6 |
12/65 (0.185) |
Mitotic roles of Polo-Like kinase |
7.37E-5 |
11/69 (0.159) |
Estrogen-mediated S-phase entry |
4.91E-4 |
6/28 (0.214) |
Cell Cycle: G2/M DNA damage checkpoint regulation |
5.07E-4 |
8/49 (0.163) |
Role of CHK proteins in cell cycle checkpoint control |
5.37E-4 |
9/56 (0.161) |
|
Top networks |
Associated network functions |
Score |
Cellular assembly and organization; DNA replication, recombination, and repair; Cell cycle |
47 |
Cellular assembly and organization, Cell cycle, DNA replication, recombination, and repair |
43 |
Cell cycle; DNA replication, recombination, and repair; Cancer |
37 |
Digestive system development and function, organismal injury and abnormalities, cellular function and maintenance |
37 |
Cellular assembly and organization; DNA replication, recombination, and repair; Cardiovascular disease |
35 |